C
The startup develops precision imaging products that detect active Granzyme B, a key biomarker for assessing immune response to immuno-oncology therapies. This technology provides healthcare providers and drug developers with timely insights into patient responses, facilitating earlier treatment adjustments and accelerating drug evaluation processes.
Sudbury, United Kingdom
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops precision imaging products that detect active Granzyme B, a key biomarker for assessing immune response to immuno-oncology therapies. This technology provides healthcare providers and drug developers with timely insights into patient responses, facilitating earlier treatment adjustments and accelerating drug evaluation processes.